/PRNewswire/ Amicrobe, Inc. develops synthetic biologics with physical and antimicrobial properties, called Amicidins. Today, the Company announced the.
U.S. Patent No. 11,285,189 is focused on safety in the prevention and treatment of infections with Amicidin technology.
CARLSBAD, Calif., April 26, 2022 .
/PRNewswire/ Today, Amicrobe, Inc. announced the issue of U.S. Patent No. 11,285,189, entitled "Compositions and uses of locally applied antimicrobials with.
U.S. Patent No. 11,285,189 is focused on safety in the prevention and treatment of infections with Amicidin technology. CARLSBAD, Calif., April 26, 2022 /PRNewswire/ Today, Amicrobe
/PRNewswire/ Today, Amicrobe, Inc. announced the issue of U.S. Patent No. 11,285,189, entitled "Compositions and uses of locally applied antimicrobials with.